Phase Ⅱ Dose Response Study of NPO-13 in Patients Undergoing Total Colonoscopy
Latest Information Update: 17 Nov 2021
At a glance
- Drugs NPO 13 (Primary)
- Indications Intestinal disorders
- Focus Therapeutic Use
- Sponsors Nihon Pharmaceutical
- 14 Apr 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 24 Oct 2014 New trial record